News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BTG Strengthens Drug Portfolio In Diseases Of Aging



10/19/2005 5:11:11 PM

May 4, 2004--BTG (LSE:BGC), the intellectual property and technology commercialization company, announced today that it has acquired two innovative drug discovery programs from King's College London. These acquisitions will strengthen BTG's portfolio in the areas of diabetes and neurodegeneration -- two major focus areas of BTG's Ageing & Neuroscience Business Unit.

Read at BioSpace.com


comments powered by Disqus
BTG, Inc.
BTG plc
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES